FABRAZYME 35 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
FABRAZYME 35 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Commercialized
Register Number
01188001
Prescription Type
Uso Hospitalario
Authorization Date
Aug 30, 2001
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number01188001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
AGALSIDASA BETAActive
Quantity: 5 mg
Name: AGALSIDASA BETA
ATC CLASSIFICATION (3)
A16A
A16AB
A16AB04